Short Interest in Xilio Therapeutics, Inc. (NASDAQ:XLO) Decreases By 17.1%
Xilio Therapeutics, Inc. (NASDAQ:XLO – Get Free Report) was the recipient of a large decline in short interest in the month of March. As of March 15th, there was short interest totalling 575,500 shares, a decline of 17.1% from the February 28th total of 694,600 shares. Approximately 3.5% of the company’s stock are short sold. […]
Xilio Therapeutics, Inc. (NASDAQ:XLO – Get Free Report) was the recipient of a large decline in short interest in the month of March. As of March 15th, there was short interest totalling 575,500 shares, a decline of 17.1% from the February 28th total of 694,600 shares. Approximately 3.5% of the company’s stock are short sold. […]
